Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pediatr Med Chir ; 17(6): 587-9, 1995.
Artículo en Italiano | MEDLINE | ID: mdl-8668599

RESUMEN

Authors reports the case of a seven months toddler with transient hyperphosphatasemia without clinical manifestations and no other hepatic or bone disfunctions. Resolution of both enzymes and bone isoenzymes occurs within 5 months.


Asunto(s)
Fosfatasa Alcalina/sangre , Isoenzimas/sangre , Monoéster Fosfórico Hidrolasas/sangre , Electroforesis en Gel de Agar , Femenino , Humanos , Lactante , Neuraminidasa/sangre , Factores de Tiempo
2.
Acta Neuropathol ; 86(3): 265-74, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8213085

RESUMEN

Neurofibrillary tangles (NFT), one of the neurodegenerative features of Alzheimer's disease, Down's syndrome and normal aging, is a constant, widespread neuropathological finding in Guamanian amyotrophic lateral sclerosis (ALS), parkinsonism-dementia (PD) and in neurologically normal Guamanians, dying of causes other than ALS and PD. NFT in brain tissue sections of patients with Guamanian ALS and PD were immunoreactive to antibodies directed against a 43-amino acid synthetic peptide homologous to amyloid beta/A4-protein (anti-SP43) associated with Alzheimer's disease. NFT extracted from frozen brain tissues of Guamanian patients with ALS and PD and from tissues of neurologically normal Guamanians were congophilic and birefringent. By negative-stain electron microscopy, NFT preparations contained bundles and/or isolated single, straight, unpaired filaments in Guamanian ALS and occasionally pairing of filaments in neurologically normal Guamanians, measuring 5-20 nm in diameter. Formic acid digestion of NFT preparations, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and size-exclusion high-pressure liquid chromatography, showed a protein with an apparent molecular mass of 4- to 4.5-kDa, which by Western blot analysis was immunoreactive to anti-SP43. Immunoabsorption of purified NFT or SP43 with anti-SP43 abolished immunostaining. Our study corroborate previous data that amyloid beta/A4-protein is present in NFT in Guamanian PD. Furthermore, our data indicate that amyloid beta/A4-protein is present in NFT in brain tissues of patients with Guamanian ALS and in neurologically normal Guamanians, suggesting a common mechanism of amyloidogenesis with NFT formation in Alzheimer's disease and normal brain aging.


Asunto(s)
Péptidos beta-Amiloides/inmunología , Esclerosis Amiotrófica Lateral/patología , Demencia/patología , Proteínas del Tejido Nervioso/metabolismo , Ovillos Neurofibrilares/patología , Enfermedad de Parkinson/patología , Western Blotting , Proteínas Portadoras/metabolismo , Cromatografía Líquida de Alta Presión , Rojo Congo , Demencia/etiología , Electroforesis en Gel de Poliacrilamida , Femenino , Guam , Humanos , Inmunohistoquímica , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Proteínas del Tejido Nervioso/inmunología , Ovillos Neurofibrilares/inmunología , Enfermedad de Parkinson/complicaciones
3.
Nature ; 355(6361): 649-52, 1992 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-1531698

RESUMEN

When fully grown Xenopus oocytes are stimulated by progesterone, a period of protein synthesis is necessary for maturation. Synthesis of the mos proto-oncogene product, pp39mos, is necessary for the activation of M-phase promoting factor (MPF) in meiosis I. On the basis that mos is translated de novo on hormonal stimulation of Xenopus oocytes and that injecting mos RNA into oocytes induces their maturation, we have proposed that the mos protein is a candidate initiator of oocyte maturation, needed to trigger the conversion of precursor MPF into its active form. To determine whether mos is the only protein required for initiating maturation, we have produced a soluble, active recombinant mos protein and injected it into Xenopus oocytes. We report here that in the absence of protein synthesis that mos protein efficiently induces germinal vesicle breakdown and the activation of MPF. The oocytes, however, do not proceed into meiosis II. Thus, the mos protein fulfills the requirements of an initiator protein, but the synthesis of one or more additional proteins may be necessary to complete oocyte maturation.


Asunto(s)
Meiosis/fisiología , Proteínas Proto-Oncogénicas/fisiología , Animales , Cicloheximida/farmacología , Femenino , Vectores Genéticos , Humanos , Técnicas In Vitro , Recién Nacido , Isopropil Tiogalactósido/farmacología , Factor Promotor de Maduración/fisiología , Oocitos/efectos de los fármacos , Oocitos/fisiología , Oogénesis/fisiología , Progesterona/farmacología , Regiones Promotoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/fisiología , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-mos , Proteínas Recombinantes de Fusión/farmacología , Xenopus
4.
Proc Natl Acad Sci U S A ; 88(16): 7145-9, 1991 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-1871127

RESUMEN

The Rex protein of human T-cell leukemia virus type I (HTLV-I) was expressed in bacteria and partially purified. Rex was shown to bind in vitro specifically to an RNA sequence located in the 3' long terminal repeat of HTLV-I, named Rex-responsive element (RXRE). Rex also bound in vitro to the human immunodeficiency virus type 1 (HIV-1) Rev-responsive element (RRE), while purified HIV-1 Rev protein did not bind to the RXRE. The binding results obtained in vitro are therefore in agreement with the nonreciprocal function of Rev and Rex in vivo. Rex binds specifically to both RRE and RXRE and activates expression in both HIV-1 and HTLV-I, while Rev binds to RRE and activates only HIV-1. Binding of Rex to RRE deletion mutants previously shown to lack either the Rev-responsive or the Rex-responsive portion suggested preferential binding of Rex to a distinct target within the RRE. These results demonstrated that Rex, like Rev, acts by binding to a specific RNA target.


Asunto(s)
Productos del Gen rex/metabolismo , VIH-1/metabolismo , Virus Linfotrópico T Tipo 1 Humano/metabolismo , ARN Viral/metabolismo , Sitios de Unión , Deleción Cromosómica , Escherichia coli/genética , Productos del Gen rex/genética , Productos del Gen rex/aislamiento & purificación , VIH-1/genética , Virus Linfotrópico T Tipo 1 Humano/genética , Modelos Estructurales , Conformación de Ácido Nucleico , Unión Proteica , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Mapeo Restrictivo , Transcripción Genética
5.
New Biol ; 2(12): 1111-22, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2088501

RESUMEN

The binding of Rev protein of human immunodeficiency virus type 1 (HIV-1) to the cis-acting Rev-responsive element (RRE) was compared to the binding of a trans-dominant Rev mutant. RevBL, which inhibits Rev function. Rev and RevBL expressed in bacteria were purified and shown to bind in vitro to the RRE with similar affinities. The study of the RRE mutants indicated that Rev and RevBL bind to the same target within the RRE in vitro and in vivo. In vivo experiments demonstrated that RevBL did not increase the steady-state levels of HIV-1 mRNA or protein. These experiments suggested that additional cellular factors interacting with Rev but not with RevBL are necessary for function. The Rex protein of human T-cell leukemia virus type I (HTLV-I) is similar to Rev and acts through a sequence named Rex-responsive element (RXRE) located in the long terminal repeat of HTLV-I. We examined the function of RevBL on a hybrid mRNA molecule containing both the RRE and RXRE. While RevBL prevented Rev function, it did not affect Rex function on the mRNA containing either the RXRE or both the RRE and RXRE. Therefore, binding of RevBL to the RRE had neither positive nor negative effects on the mRNA, since this mRNA could be efficiently utilized in the presence of a functional Rex-RXRE interaction. The results obtained in vivo and in vitro strongly suggest that RevBL inhibits Rev function by binding to the same site as Rev and preventing Rev binding and function.


Asunto(s)
Productos del Gen rev/genética , Genes rev , VIH-1/genética , ARN Mensajero/metabolismo , ARN Viral , Secuencias Reguladoras de Ácidos Nucleicos , Regulación Viral de la Expresión Génica , Productos del Gen gag/biosíntesis , Productos del Gen gag/genética , Humanos , Técnicas In Vitro , Mutación , Conformación de Ácido Nucleico , Productos del Gen rev del Virus de la Inmunodeficiencia Humana
6.
AIDS Res Hum Retroviruses ; 6(6): 753-64, 1990 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1694680

RESUMEN

A better understanding of the structure and biochemical properties of the replicative machinery of human immunodeficiency virus type 1 (HIV-1) may be useful in the screening and design of drugs that could be used to treat AIDS. We have previously described a recombinant strain of Escherichia coli that produces HIV-1 reverse transcriptase (RT). Fermentation conditions for the large-scale growth of the bacterial strain and a protocol for the purification of an enzymatically active 66-Kd form of the RT have been developed. The purified RT has all of the appropriate enzymatic functions and properties. The recombinant protein can be substituted for the viral enzyme in structural and biochemical studies and used in screens for drugs that could inhibit HIV replication.


Asunto(s)
VIH-1/enzimología , ADN Polimerasa Dirigida por ARN/aislamiento & purificación , Biotecnología , ADN Polimerasa Dirigida por ADN/aislamiento & purificación , Estabilidad de Medicamentos , Endorribonucleasas/aislamiento & purificación , Escherichia coli/enzimología , Escherichia coli/genética , Fermentación , VIH-1/genética , ADN Polimerasa Dirigida por ARN/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Ribonucleasa H , Especificidad por Sustrato
7.
NMR Biomed ; 1(3): 136-50, 1988 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3079310

RESUMEN

An evaluation of the reproducibility and accuracy of the NMR human blood test for cancer described by Fossel, E. T., Carr, J. M. and McDonagh, J., (New England Journal of Medicine 315, 1369-1376) in 1986 has been conducted jointly at the National Cancer Institute-Frederick Cancer Research Facility, Frederick, MD (NCI-FCRF) and the National Research Council, Ottawa, Canada (NRC). The influences on the test of the following were studied: (a) subject fasting; (b) sample collection, storage and handling; (c) use of plasma or serum; (d) variations of test results from the same individual with time; (e) NMR observation parameters including field strength and temperature; and (f) variations in obtaining the Fossel Index (FI) (a number defined by Fossel and co-workers as the average of the widths at half height of the regions in the NMR spectrum of human plasma at 1.3 and 0.88 ppm) by different people from the same plotted spectrum. This test was found to be reproducible but not accurate for screening a general asymptomatic population. The accuracy is defined in terms of the sensitivity, specificity, and predictive values of the test. The accuracy of the test results from our laboratories is compared with the accuracies from other laboratories including Fossel's. The correlation of the Fossel Index with total triglyceride content in the serum has been confirmed by analysing blood components using the following technologies: KBr density gradient centrifugation, high resolution agarose gel electrophoresis, high performance gel permeation chromatography, and chemical analysis.


Asunto(s)
Espectroscopía de Resonancia Magnética , Neoplasias/diagnóstico , Análisis Químico de la Sangre , Estudios de Evaluación como Asunto , Humanos , Lipoproteínas/sangre , Neoplasias/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA